161 related articles for article (PubMed ID: 16959899)
1. A CD34(+) human cell line model of myeloid dendritic cell differentiation: evidence for a CD14(+)CD11b(+) Langerhans cell precursor.
Santegoets SJ; Masterson AJ; van der Sluis PC; Lougheed SM; Fluitsma DM; van den Eertwegh AJ; Pinedo HM; Scheper RJ; de Gruijl TD
J Leukoc Biol; 2006 Dec; 80(6):1337-44. PubMed ID: 16959899
[TBL] [Abstract][Full Text] [Related]
2. Human CD34+ CD11b- cord blood stem cells generate in vitro a CD34- CD11b+ subset that is enriched in langerin+ Langerhans dendritic cell precursors.
Soulas C; Arrighi JF; Saeland S; Chapuis B; Kindler V
Exp Hematol; 2006 Nov; 34(11):1471-9. PubMed ID: 17046566
[TBL] [Abstract][Full Text] [Related]
3. CD34+ cell-derived CD14+ precursor cells develop into Langerhans cells in a TGF-beta 1-dependent manner.
Jaksits S; Kriehuber E; Charbonnier AS; Rappersberger K; Stingl G; Maurer D
J Immunol; 1999 Nov; 163(9):4869-77. PubMed ID: 10528188
[TBL] [Abstract][Full Text] [Related]
4. TNF-alpha induces the generation of Langerin/(CD207)+ immature Langerhans-type dendritic cells from both CD14-CD1a and CD14+CD1a- precursors derived from CD34+ cord blood cells.
Arrighi JF; Soulas C; Hauser C; Saeland S; Chapuis B; Zubler RH; Kindler V
Eur J Immunol; 2003 Jul; 33(7):2053-63. PubMed ID: 12884872
[TBL] [Abstract][Full Text] [Related]
5. Selective generation of different dendritic cell precursors from CD34+ cells by interleukin-6 and interleukin-3.
Encabo A; Solves P; Mateu E; Sepúlveda P; Carbonell-Uberos F; Miñana MD
Stem Cells; 2004; 22(5):725-40. PubMed ID: 15342937
[TBL] [Abstract][Full Text] [Related]
6. TLR agonists induce the differentiation of human bone marrow CD34+ progenitors into CD11c+ CD80/86+ DC capable of inducing a Th1-type response.
Sioud M; Fløisand Y
Eur J Immunol; 2007 Oct; 37(10):2834-46. PubMed ID: 17853407
[TBL] [Abstract][Full Text] [Related]
7. Constitutively active STAT5b induces cytokine-independent growth of the acute myeloid leukemia-derived MUTZ-3 cell line and accelerates its differentiation into mature dendritic cells.
Bontkes HJ; Ruizendaal JJ; Kramer D; Santegoets SJ; Scheper RJ; de Gruijl TD; Meijer CJ; Hooijberg E
J Immunother; 2006; 29(2):188-200. PubMed ID: 16531819
[TBL] [Abstract][Full Text] [Related]
8. CD34 human hematopoietic progenitor cell line, MUTZ-3, differentiates into functional osteoclasts.
Ciraci E; Barisani D; Parafioriti A; Formisano G; Arancia G; Bottazzo G; Berardi AC
Exp Hematol; 2007 Jun; 35(6):967-77. PubMed ID: 17533051
[TBL] [Abstract][Full Text] [Related]
9. Aryl hydrocarbon receptor activation inhibits in vitro differentiation of human monocytes and Langerhans dendritic cells.
Platzer B; Richter S; Kneidinger D; Waltenberger D; Woisetschläger M; Strobl H
J Immunol; 2009 Jul; 183(1):66-74. PubMed ID: 19535631
[TBL] [Abstract][Full Text] [Related]
10. Initial human myeloid/dendritic cell progenitors identified by absence of myeloperoxidase protein expression.
Scholz W; Platzer B; Schumich A; Höcher B; Fritsch G; Knapp W; Strobl H
Exp Hematol; 2004 Mar; 32(3):270-6. PubMed ID: 15003312
[TBL] [Abstract][Full Text] [Related]
11. MUTZ-3-derived dendritic cells as an in vitro alternative model to CD34+ progenitor-derived dendritic cells for testing of chemical sensitizers.
Nelissen I; Selderslaghs I; Heuvel RV; Witters H; Verheyen GR; Schoeters G
Toxicol In Vitro; 2009 Dec; 23(8):1477-81. PubMed ID: 19732821
[TBL] [Abstract][Full Text] [Related]
12. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells.
de Witte L; Nabatov A; Pion M; Fluitsma D; de Jong MA; de Gruijl T; Piguet V; van Kooyk Y; Geijtenbeek TB
Nat Med; 2007 Mar; 13(3):367-71. PubMed ID: 17334373
[TBL] [Abstract][Full Text] [Related]
13. A nonredundant role for canonical NF-κB in human myeloid dendritic cell development and function.
van de Laar L; van den Bosch A; van der Kooij SW; Janssen HL; Coffer PJ; van Kooten C; Woltman AM
J Immunol; 2010 Dec; 185(12):7252-61. PubMed ID: 21076069
[TBL] [Abstract][Full Text] [Related]
14. Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: possible application for cancer immunotherapy.
Harada S; Kimura T; Fujiki H; Nakagawa H; Ueda Y; Itoh T; Yamagishi H; Sonoda Y
Int J Oncol; 2007 Jun; 30(6):1461-8. PubMed ID: 17487367
[TBL] [Abstract][Full Text] [Related]
15. Preferential Langerhans cell differentiation from CD34(+) precursors upon introduction of ABCG2 (BCRP).
van de Ven R; Lindenberg JJ; Reurs AW; Scheper RJ; Scheffer GL; de Gruijl TD
Immunol Cell Biol; 2012 Feb; 90(2):206-15. PubMed ID: 21445088
[TBL] [Abstract][Full Text] [Related]
16. Myeloid cell differentiation in response to calcitriol for expression CD11b and CD14 is regulated by myeloid zinc finger-1 protein downstream of phosphatidylinositol 3-kinase.
Moeenrezakhanlou A; Shephard L; Lam L; Reiner NE
J Leukoc Biol; 2008 Aug; 84(2):519-28. PubMed ID: 18495781
[TBL] [Abstract][Full Text] [Related]
17. Both Langerhans cells and interstitial DC cross-present melanoma antigens and efficiently activate antigen-specific CTL.
Cao T; Ueno H; Glaser C; Fay JW; Palucka AK; Banchereau J
Eur J Immunol; 2007 Sep; 37(9):2657-67. PubMed ID: 17683111
[TBL] [Abstract][Full Text] [Related]
18. Hematopoiesis of immature myeloid dendritic cells in stroma-dependent spleen long-term cultures occurs independently of NF-KB/RelB function.
Tan JK; Ni K; Le F; O'Neill HC
Exp Hematol; 2007 Oct; 35(10):1580-93. PubMed ID: 17889723
[TBL] [Abstract][Full Text] [Related]
19. Correlation between differentiation plasticity and mRNA expression profiling of CD34+-derived CD14- and CD14+ human normal myeloid precursors.
Montanari M; Gemelli C; Tenedini E; Zanocco Marani T; Vignudelli T; Siena M; Zini R; Salati S; Chiossi G; Tagliafico E; Manfredini R; Grande A; Ferrari S
Cell Death Differ; 2005 Dec; 12(12):1588-600. PubMed ID: 15947790
[TBL] [Abstract][Full Text] [Related]
20. CD14+ CD34+ peripheral blood mononuclear cells migrate across endothelium and give rise to immunostimulatory dendritic cells.
Ferrero E; Bondanza A; Leone BE; Manici S; Poggi A; Zocchi MR
J Immunol; 1998 Mar; 160(6):2675-83. PubMed ID: 9510166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
